2024 | Association between long-term PM2.5 exposure and risk of Kawasaki disease in children: A nationwide longitudinal cohort study | 하은희; 김혜순; 이지영; 이정원; 이환희; 이지현 | Article |
2018 | C-reactive protein and N-terminal pro-brain natriuretic peptide discrepancy: A differentiation of adenoviral pharyngoconjunctival fever from Kawasaki disease | 홍영미; 손세정 | Article |
2023 | Identification of B-cell-related HSPG2 and CDSN as susceptibility loci for Kawasaki disease | 홍영미 | Article |
2019 | Identification of the TIFAB Gene as a Susceptibility Locus for Coronary Artery Aneurysm in Patients with Kawasaki Disease | 홍영미; 손세정 | Article |
2016 | INFLIXIMAB AS THE FIRST RETREATMENT IN PATIENTS WITH KAWASAKI DISEASE RESISTANT TO INITIAL INTRAVENOUS IMMUNOGLOBULIN | 홍영미; 손세정 | Article |
2019 | Infliximab treatment for intravenous immunoglobulin-resistant kawasaki disease: A multicenter study in Korea | 손세정 | Article |
2006 | Insertion/deletion polymorphism of angiotensin converting enzyme gene in Kawasaki disease | 홍영미; 김혜순; 손세정 | Article |
2021 | Is Short-Term Exposure to PM2.5 Relevant to Childhood Kawasaki Disease? | 하은희; 김혜순; 이지현 | Article |
2017 | Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes | 홍영미 | Article |
2015 | Uveitis as an important ocular sign to help early diagnosis in Kawasaki disease | 홍영미; 김혜순; 손세정; 권정현 | Article |